Metropolis Healthcare Intrinsic Value

Metropolis Healthcare intrinsic value. Metropolis Healthcare (METROPOLIS) median intrinsic value is ₹726.19 from 10 valuation models (range ₹168–₹1117), vs current price ₹558.70 — +30.0% upside (Trading Below Calculated Value), margin of safety 23.1%. Analyse METROPOLIS FII DII holdings to track promoter, FII and institutional holdings.

Market Price (CMP)
₹558.70
Primary Intrinsic Value
₹320.32
Market Cap
₹2347 Cr
+30.0% Upside
Median Value
₹726.19
Value Range
₹168 - ₹1117
Assessment
Trading Below Calculated Value
Safety Margin
23.1%

METROPOLIS Valuation Methods Summary — DCF, Graham Number & P/E

Metropolis Healthcare intrinsic value across 10 models vs current price ₹558.70 — upside/downside and value range per method. Browse METROPOLIS income statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹320.32 ₹256.26 - ₹384.38 -42.7% EPS: ₹14.56, Sector P/E: 22x
Book Value Method asset ₹726.19 ₹653.57 - ₹798.81 +30.0% Book Value/Share: ₹363.10, P/B: 2.0x
Revenue Multiple Method revenue ₹961.90 ₹865.71 - ₹1058.09 +72.2% Revenue/Share: ₹480.95, P/S: 2.0x
EBITDA Multiple Method earnings ₹1117.40 ₹1005.66 - ₹1229.14 +100.0% EBITDA: ₹572.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹889.37 ₹711.50 - ₹1067.24 +59.2% CF Growth: 8.5%, Discount: 15%
PEG Ratio Method growth ₹167.61 ₹150.85 - ₹184.37 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹224.95 ₹202.45 - ₹247.45 -59.7% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹1013.33 ₹912.00 - ₹1114.66 +81.4% ROE: 19.9%, P/E Multiple: 14x
Graham Defensive Method conservative ₹344.89 ₹310.40 - ₹379.38 -38.3% EPS: ₹14.56, BVPS: ₹363.10
Dividend Yield Method dividend ₹200.00 ₹180.00 - ₹220.00 -64.2% DPS: ₹5.00, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

METROPOLIS Intrinsic Value vs Market Price — All Valuation Models

Metropolis Healthcare fair value range ₹168–₹1117 vs current market price ₹558.70 across 10 valuation models. For current market price and key ratios, visit METROPOLIS share price screener.

METROPOLIS Intrinsic Value Analysis — Undervalued or Overvalued?

Metropolis Healthcare median intrinsic value ₹726.19, current price ₹558.70 — Trading Below Calculated Value by 30.0%, margin of safety 23.1%.

What is the intrinsic value of METROPOLIS?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Metropolis Healthcare (METROPOLIS) is ₹726.19 (median value). With the current market price of ₹558.70, this represents a +30.0% variance from our estimated fair value.

The valuation range spans from ₹167.61 to ₹1117.40, indicating ₹167.61 - ₹1117.40.

Is METROPOLIS undervalued or overvalued?

Based on our multi-method analysis, Metropolis Healthcare (METROPOLIS) appears to be trading below calculated value by approximately 30.0%.

METROPOLIS Financial Health — Key Ratios vs Industry Benchmarks

Metropolis Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 19.9% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 27.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.94x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

METROPOLIS Cash Flow Quality — Operating & Free Cash Flow

Metropolis Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹351 Cr ₹241 Cr Positive Free Cash Flow 8/10
March 2025 ₹263 Cr ₹164 Cr Positive Free Cash Flow 8/10
March 2024 ₹264 Cr ₹220 Cr Positive Free Cash Flow 8/10
March 2023 ₹247 Cr ₹247 Cr Positive Free Cash Flow 8/10
March 2022 ₹253 Cr ₹-115 Cr Positive Operating Cash Flow 6/10